Central Visual Impairment

4

Review clinical trials related to Central Visual Impairment. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Study of Taste- and Olfactory-Evoked Potentials in Patients With Visual Impairment: Taste, Smell, and Vision

Visual impairment, whether central or peripheral, may influence the plasticity of other sensory modalities, such as taste and smell. Taste-evoked potentials (TEPs) and smell-evoked potentials (SEPs)-methods for analyzing brain activity in response to taste and smell stimuli-allow for the objective assessment of these interactions. This approach has already demonstrated its value in the study of cognitive disorders. This study aims to demonstrate an enhancement of taste and smell capabilities that could compensate for specific visual impairments, particularly in situations involving food choices.

Participants needed: 50
Trial details
Age: 18-60Biological sex: AllType: InterventionalSponsor: Centre Hospitalier Universitaire DijonUpdated: Jul 16, 2026Locations: 1
Eligibility criteria

Adult: ≥ 18 years and ≤ 60 years [+3]

Individuals who are not enrolled in or eligible for a social security program [+11]

Status: Not yet recruiting

Remapping Text in Sentence and Word Tasks to Aid Reading With Central Vision Loss

Reading performance in patients with Central Vision Loss will be measured with and without missing text being remapped to different parts of the visual field in a variety of different reading tasks.

Participants needed: 100
Trial details
Age: 16+Biological sex: AllType: InterventionalSponsor: University of MinnesotaUpdated: Jul 7, 2026Locations: 1
Eligibility criteria

Dense bilateral scotomas of at least 2 deg diameter in each eye covering the fov... [+1]

Neovascular AMD [+1]

Status: Recruiting

Vision Rehabilitation Training With Multimodal Feedback in Central Vision Loss

Central vision loss from macular degeneration creates blind spots that impair reading, face recognition, and navigation. Individuals must learn to use peripheral vision, requiring retraining of eye movements. Our preliminary research using high-speed eye tracking demonstrated that people with larger scotomas have impaired eye movement control, and that single-session visual feedback training showed limited immediate benefit, though combining feedback types showed promise. This study will evaluate whether extended binocular training (5 weekly sessions) with multimodal feedback improves eye movement control in 8-15 participants with bilateral central vision loss. Unlike conventional monocular rehabilitation systems, our approach trains both eyes simultaneously using real-time visual and auditory feedback during saccadic and smooth pursuit tasks. Participants will receive gaze-contingent scotoma awareness feedback, preferred retinal locus feedback, and auditory cues while performing eye tracking exercises. Primary outcomes include saccadic accuracy (latency, landing error, amplitude) and smooth pursuit parameters (gain, tracking accuracy). Secondary outcomes include contrast sensitivity and self-reported visual function. Success could establish an evidence base for accessible home-based training using virtual reality technology, potentially benefiting millions with macular degeneration.

Participants needed: 12
Trial details
Age: 14+Biological sex: AllType: InterventionalSponsor: New England College of OptometryUpdated: May 11, 2026Locations: 1
Eligibility criteria

Not listed

Status: Recruiting

Factors in Learning And Plasticity: Macular Degeneration

A greater understanding of plasticity after central vision loss can inform new therapies for treating low vision and has the potential to benefit millions of individuals suffering from low vision. The treatment of low vision is particularly relevant to the mission of the NEI to support research on visual disorders, mechanisms of visual function, and preservation of sight. The comparison of different training and outcome factors is in line with the NIMH RDOC framework and studies in an aging population are consistent with the mission of the NIA.

Participants needed: 60
Trial details
Age: 18-89Biological sex: AllType: InterventionalSponsor: University of Alabama at BirminghamUpdated: Feb 9, 2026Locations: 1
Eligibility criteria

Aged 18-89 [+5]

Pacemaker or any ferromagnetic metal implanted in their body [+10]